DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Cortes J, Cescon DW, Rugo HS. et al.
KEYNOTE-355: Randomized, double-blind, phase III study of pembrolizumab + chemotherapy versus placebo + chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer.
J Clin Oncol 2020;
38: 1000-1000
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.